ABSTRACT
The quest for chemicals able to operate at selected genomic loci in a spatiotemporally controlled manner is desirable to create manageable DNA damages. Mounting evidence now shows that alternative DNA structures, including G-quadruplexes and branched DNA (or DNA junctions), might hamper proper progression of replication fork, thus triggering DNA damages and genomic instability. Therefore, small molecules that stabilize these DNA structures are currently scrutinized as a promising way to create genomic defects that cannot be dealt with properly by cancer cells. While much emphasis has been recently given to G-quadruplexes and related ligands, we report herein on three-way DNA junctions (TWJ) and related ligands. We first highlight the biological implications of TWJ and their strategic relevance as triggers for replicative stress. Then, we describe a new in vitro high-throughput screening assay, TWJ-Screen, which allows for identifying TWJ ligands with both high affinity and selectivity for TWJ over other DNA structures (duplexes and quadruplexes), in a convenient and unbiased manner as demonstrated by the screening of a library of 25 compounds from different chemical families. TWJ-Screen thus represents a reliable mean to uncover molecular tools able to foster replicative stress through an innovative approach, thus providing new strategic opportunities to combat cancers.
Subject(s)
DNA Replication/drug effects , DNA, Cruciform/drug effects , G-Quadruplexes/drug effects , High-Throughput Screening Assays , Intercalating Agents/pharmacology , Small Molecule Libraries/pharmacology , Base Sequence , DNA Damage , Fluorescent Dyes/chemistry , Genetic Loci , Genome, Human , Genomic Instability , Humans , Intercalating Agents/chemistry , Ligands , Rhodamines/chemistry , Small Molecule Libraries/chemistry , Structure-Activity RelationshipABSTRACT
The absence of the Holliday-junction Ruv resolvase of Mycobacterium smegmatis increased the bacteriostatic and bactericidal activities of the fluoroquinolone moxifloxacin, an important antituberculosis agent. The treatment of ruvAB-deficient cells with thiourea and 2,2'-bipyridyl lowered moxifloxacin lethality to wild-type levels, indicating that the absence of ruvAB stimulates a lethal pathway involving reactive oxygen species. A hexapeptide that traps the Holliday junction substrate of RuvAB potentiated moxifloxacin-mediated lethality, supporting the development of small-molecule enhancers for moxifloxacin activity against mycobacteria.
Subject(s)
Fluoroquinolones/pharmacology , Holliday Junction Resolvases/metabolism , Mycobacterium smegmatis/drug effects , Mycobacterium smegmatis/metabolism , Antitubercular Agents/pharmacology , DNA, Cruciform/drug effects , DNA, Cruciform/metabolism , DNA-Binding Proteins/metabolism , Moxifloxacin , Reactive Oxygen Species/metabolism , Thiourea/pharmacologyABSTRACT
Helicases that both unwind and rewind DNA have central roles in DNA repair and genetic recombination. In contrast to unwinding, DNA rewinding by helicases has proved difficult to characterize biochemically because of its thermodynamically downhill nature. Here we use single-molecule assays to mechanically destabilize a DNA molecule and follow, in real time, unwinding and rewinding by two DNA repair helicases, bacteriophage T4 UvsW and Escherichia coli RecG. We find that both enzymes are robust rewinding enzymes, which can work against opposing forces as large as 35 pN, revealing their active character. The generation of work during the rewinding reaction allows them to couple rewinding to DNA unwinding and/or protein displacement reactions central to the rescue of stalled DNA replication forks. The overall results support a general mechanism for monomeric rewinding enzymes.
Subject(s)
Biocatalysis , DNA Helicases/metabolism , DNA Replication , DNA/chemistry , DNA/metabolism , Escherichia coli Proteins/metabolism , Viral Proteins/metabolism , Bacteriophage T4/enzymology , Biocatalysis/drug effects , Biomechanical Phenomena/drug effects , DNA Replication/drug effects , DNA, Cruciform/drug effects , DNA, Cruciform/metabolism , Escherichia coli/enzymology , Magnesium/pharmacology , Magnetic Phenomena , Optical Tweezers , Osmolar Concentration , Substrate Specificity/drug effectsABSTRACT
DNA repair pathways in bacteria that use homologous recombination involve the formation and subsequent resolution of Holliday junction (HJ) intermediates. We have previously identified several hexameric peptides that bind to HJs and interfere with HJ processing enzymes in vitro. The peptide WRWYCR and its D-amino acid stereoisomer wrwycr, are potent antibacterial agents. These hexapeptides must form homodimers in order to interact stably with HJs, and inhibit bacterial growth, and this represents a potential limitation. Herein we describe a disulfide bond-independent inhibitor, WRWYRGGRYWRW and its D-stereoisomer wrwyrggrywrw. We have characterized these single-chain, linear analogs of the hexapeptides, and show that in addition to effectively binding to HJs, and inhibiting the activity of DNA repair enzymes that process HJs, they have equal or greater potency against Gram-positive and Gram-negative bacterial growth. The analogs were also shown to cause DNA damage in bacteria, and disrupt the integrity of the bacterial cytoplasmic membrane. Finally, we found that they have little toxicity toward several eukaryotic cell types at concentrations needed to inhibit bacterial growth.
Subject(s)
Bacteria/drug effects , DNA Damage/drug effects , DNA, Cruciform/chemistry , Peptides/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , DNA Repair/drug effects , DNA Repair/genetics , DNA, Cruciform/drug effects , DNA, Cruciform/metabolism , Homologous Recombination/drug effects , Peptides/chemistry , Protein Multimerization , StereoisomerismABSTRACT
Our lab has isolated hexameric peptides that are structure-selective ligands of Holliday junctions (HJ), central intermediates of several DNA recombination reactions. One of the most potent of these inhibitors, WRWYCR, has shown antibacterial activity in part due to its inhibition of DNA repair proteins. To increase the therapeutic potential of these inhibitors, we searched for small molecule inhibitors with similar activities. We screened 11 small molecule libraries comprising over nine million individual compounds and identified a potent N-methyl aminocyclic thiourea inhibitor that also traps HJs formed during site-specific recombination reactions in vitro. This inhibitor binds specifically to protein-free HJs and can inhibit HJ resolution by RecG helicase, but only showed modest growth inhibition of bacterial with a hyperpermeable outer membrane; nonetheless, this is an important step in developing a functional analog of the peptide inhibitors.
Subject(s)
Anti-Bacterial Agents/chemistry , DNA, Cruciform/drug effects , Nitro Compounds/chemistry , Peptides/pharmacology , Propylamines/chemistry , Recombination, Genetic/drug effects , Small Molecule Libraries/chemistry , Amino Acid Sequence , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Bacteriophage lambda/enzymology , Combinatorial Chemistry Techniques , DNA Repair/drug effects , Integrases , Nitro Compounds/pharmacology , Propylamines/pharmacology , Small Molecule Libraries/pharmacologyABSTRACT
The hexapeptide WRWYCR was previously identified on the basis of its ability to inhibit bacteriophage lambda integrase-mediated recombination by trapping and preventing resolution of the Holliday junction intermediate. This peptide inhibits several unrelated DNA repair enzymes that bind to and process Holliday junctions and branched DNA substrates. WRWYCR and its d stereoisomer, wrwycr, are bactericidal against both Gram-positive and Gram-negative bacteria, causing the accumulation of DNA breaks, chromosome segregation defects, and the filamentation of cells. DNA repair is a novel target of antibiotics. In the present study, we examined the ability of the peptides to inhibit the growth of Salmonella in mammalian cells. J774A.1 macrophage-like cells and murine peritoneal macrophages were infected with Salmonella enterica serovar Typhimurium and grown in the presence or absence of peptide. We found that peptide wrwycr reduced the number of Salmonella cells recovered after 24 h growth in J774A.1 cells by 100 to 1,000 times, depending on the multiplicity of infection. The peptide also inhibited Salmonella growth in peritoneal macrophages, and although higher doses were required, these were not toxic to the host cells. The apparent lower level of potency of the peptide paralleled the lower level of replication of Salmonella and the lower level of permeation of the peptide in the peritoneal macrophages than in the J774.1 cells. Treatment with peptide wrwycr elicited the SOS response in a significant fraction of the intracellular bacteria, as would be expected if the mechanism of bacterial killing was the same in pure culture and in host cells. These results represent a proof of principle of the antimicrobial activities of compounds that target DNA repair.
Subject(s)
Antimicrobial Cationic Peptides/pharmacokinetics , DNA Repair/drug effects , Macrophages, Peritoneal/microbiology , Salmonella Infections, Animal/drug therapy , Salmonella typhimurium , Animals , Cell Line , Chromatography, High Pressure Liquid , DNA, Cruciform/drug effects , Female , Gene Expression Regulation, Bacterial/drug effects , In Vitro Techniques , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred BALB C , SOS Response, Genetics/drug effects , Salmonella Infections, Animal/physiopathology , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Salmonella typhimurium/growth & development , TemperatureABSTRACT
Chemotherapy has been a major approach to treat cancer. Both constituents of chromatin, chromosomal DNA and the associated chromosomal histone proteins are the molecular targets of the anticancer drugs. Small DNA binding ligands, which inhibit enzymatic processes with DNA substrate, are well known in cancer chemotherapy. These drugs inhibit the polymerase and topoisomerase activity. With the advent in the knowledge of chromatin chemistry and biology, attempts have shifted from studies of the structural basis of the association of these drugs or small ligands (with the potential of drugs) with DNA to their association with chromatin and nucleosome. These drugs often inhibit the expression of specific genes leading to a series of biochemical events. An overview will be given about the latest understanding of the molecular basis of their action. We shall restrict to those drugs, synthetic or natural, whose prime cellular targets are so far known to be chromosomal DNA.
Subject(s)
Antineoplastic Agents/pharmacology , Chromatin Assembly and Disassembly/drug effects , Chromatin/drug effects , DNA/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Animals , Antibiotics, Antineoplastic/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents, Alkylating/pharmacology , Chromatin/chemistry , Chromatin/metabolism , Cross-Linking Reagents/pharmacology , Crystallography , DNA/chemistry , DNA/metabolism , DNA Adducts/drug effects , DNA Methylation/drug effects , DNA Modification Methylases/antagonists & inhibitors , DNA, Cruciform/drug effects , Enzyme Inhibitors/pharmacology , Epigenesis, Genetic/drug effects , G-Quadruplexes , Humans , Intercalating Agents/pharmacology , Molecular Structure , Nucleic Acid Conformation , Nucleic Acid Synthesis Inhibitors , Thermodynamics , Topoisomerase InhibitorsABSTRACT
The Holliday junction (HJ) is a central intermediate of homologous recombination. Its cleavage is critical for the formation of crossover recombinants during meiosis, which in turn helps to establish chiasmata and promote genetic diversity. Enzymes that cleave HJs, called HJ resolvases, have been identified in all domains of life except eukaryotic nuclei. Controversially, the Mus81-Eme1 endonuclease has been proposed to be an example of a eukaryotic nuclear resolvase. However, hitherto little or no HJ cleavage has been detected in recombinant preparations of Mus81-Eme1. Here, we report the purification of active forms of recombinant Schizosaccharomyces pombe Mus81-Eme1 and Saccharomyces cerevisiae Mus81-Mms4, which display robust HJ cleavage in vitro, which, in the case of Mus81-Eme1, is as good as the archetypal HJ resolvase RuvC in single turnover kinetic analysis. We also present genetic evidence that suggests that this activity might be utilised as a back-up to Mus81-Eme1's main activity of cleaving nicked HJs during meiosis in S. pombe.
Subject(s)
DNA, Cruciform/metabolism , DNA-Binding Proteins/metabolism , Endonucleases/metabolism , Meiosis , Recombination, Genetic/genetics , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Schizosaccharomyces pombe Proteins/metabolism , Schizosaccharomyces/metabolism , Base Sequence , Crossing Over, Genetic/drug effects , DNA, Cruciform/drug effects , DNA, Cruciform/genetics , DNA-Binding Proteins/isolation & purification , Endodeoxyribonucleases/metabolism , Endonucleases/isolation & purification , Escherichia coli Proteins/metabolism , Flap Endonucleases , Magnesium/pharmacology , Meiosis/drug effects , Models, Genetic , Molecular Sequence Data , Recombinant Proteins/isolation & purification , Recombination, Genetic/drug effects , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae Proteins/isolation & purification , Schizosaccharomyces/drug effects , Schizosaccharomyces pombe Proteins/isolation & purification , Trans-Activators/isolation & purification , Trans-Activators/metabolism , UltracentrifugationABSTRACT
A Holliday junction (HJ) consists of four DNA double helices, with a branch point discontinuity at the intersection of the component strands. At low ionic strength, the HJ adopts an open conformation, with four widely spaced arms, primarily due to strong electrostatic repulsion between the phosphate groups on the backbones. At high ionic strength, screening of this repulsion induces a switch to a more compact (closed) junction conformation. Fluorescent labelling with dyes placed on the HJ arms allows this conformational switch to be detected optically using fluorescence resonance energy transfer (FRET), producing a sensitive fluorescent output of the switch state. This paper presents a systematic and quantitative survey of the switch characteristics of such a labelled HJ. A short HJ (arm length 8 bp) is shown to be prone to dissociation at low switching ion concentration, whereas an HJ of arm length 12 bp is shown to be stable over all switching ion concentrations studied. The switching characteristics of this HJ have been systematically and quantitatively studied for a variety of switching ions, by measuring the required ion concentration, the sharpness of the switching transition and the fluorescent output intensity of the open and closed states. This stable HJ is shown to have favourable switch characteristics for a number of inorganic switching ions, making it a promising candidate for use in nanoscale biomolecular switch devices.
Subject(s)
DNA, Cruciform/chemistry , DNA, Cruciform/drug effects , Fluorescent Dyes/chemistry , Ions/pharmacology , Nucleic Acid Conformation/drug effects , Spectrometry, Fluorescence , Spermidine/pharmacologyABSTRACT
Holliday junctions (HJs) are formed as transient DNA intermediates during site-specific and homologous recombination. Both of these genetic exchange pathways are critical for normal DNA metabolism and repair. Trapping HJs leads to bacterial cell death by preventing proper segregation of the resulting interlinked chromosomes. Macrocyclic peptides designed to target this intermediate were synthesized with the goal of identifying compounds with specificity for this unique molecular target. We discovered ten macrocycles, both hexameric and octameric peptides, capable of trapping HJs in vitro. Those macrocycles containing tyrosine residues proved most effective. These data demonstrate that C-2 symmetrical macrocycles offer excellent synthetic targets for the development of novel antibiotic agents. Furthermore, the active compounds identified provide valuable tools for probing different pathways of recombinational exchange.
Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , DNA, Cruciform/drug effects , DNA, Cruciform/metabolism , Endodeoxyribonucleases/metabolism , Escherichia coli Proteins/metabolism , Oligopeptides/chemical synthesis , Oligopeptides/pharmacology , Peptides, Cyclic/chemical synthesis , Peptides, Cyclic/pharmacology , Anti-Bacterial Agents/chemistry , Escherichia coli/drug effects , Escherichia coli/enzymology , In Vitro Techniques , Macromolecular Substances , Models, Molecular , Molecular Structure , Nucleic Acid Conformation , Oligopeptides/chemistry , Peptides, Cyclic/chemistry , Protein Conformation , Staphylococcus epidermidis/drug effectsABSTRACT
Holliday junction intermediates arise in several central pathways of DNA repair, replication fork restart, and site-specific recombination catalysed by tyrosine recombinases. Previously identified hexapeptide inhibitors of phage lambda integrase-mediated recombination block the resolution of Holliday junction intermediates in vitro and thereby inhibit recombination, but have no DNA cleavage activity themselves. The most potent peptides are specific for the branched DNA structure itself, as opposed to the integrase complex. Based on this activity, the peptides inhibit several unrelated Holliday junction-processing enzymes in vitro, including the RecG helicase and RuvABC junction resolvase complex. We have found that some of these hexapeptides are potent bactericidal antimicrobials, effective against both Gm+ and Gm- bacteria. Using epifluorescence microscopy and flow cytometry, we have characterized extensively the physiology of bacterial cells treated with these peptides. The hexapeptides cause DNA segregation abnormalities, filamentation and DNA damage. Damage caused by the peptides induces the SOS response, and is synergistic with damage caused by UV and mitomycin C. Our results are consistent with the model that the hexapeptides affect DNA targets that arise during recombination-dependent repair. We propose that the peptides trap intermediates in the repair of collapsed replication forks, preventing repair and resulting in bacterial death. Inhibition of DNA repair constitutes a novel target of antibiotic therapy. The peptides affect targets that arise in multiple pathways, and as expected, are quite resistant to the development of spontaneous antibiotic resistance.